Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward-Reference-Cited by-同舟云学术

Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward

Published:2022-12 Issue:12 Volume:10 Page:e1860-e1866
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Jenei Kristina,Aziz Zeba,Booth Christopher,Cappello Bernadette,Ceppi Francesco,de Vries Elisabeth G E,Fojo Antonio,Gyawali Bishal,Ilbawi Andre,Lombe Dorothy,Sengar Manju,Sullivan Richard,Trapani Dario,Huttner Benedikt D,Moja Lorenzo

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey;Fundytus;Lancet Oncol,2021

2. Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks;Del Paggio;Lancet Oncol,2017

3. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO;Piggott;BMJ Open,2022

4. Proposing essential medicines to treat cancer: methodologies, processes, and outcomes;Shulman;J Clin Oncol,2016

5. Evolution of the randomized clinical trial in the era of precision oncology;Del Paggio;JAMA Oncol,2021

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on organ-on-a-chip technology for natural products evaluation;Food & Medicine Homology;2024-12

2. Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta‐analysis;Cancer;2024-09-05

3. Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: Perspective from a low- and middle- income country in sub-Saharan Africa;Urologic Oncology: Seminars and Original Investigations;2024-08

4. Global outlook on affordability of biotherapeutic drugs;Annals of the New York Academy of Sciences;2024-06-13

5. Assessment of anticancer drug utilization pattern and patients’ survival—A single center experience from Saudi Arabia;F1000Research;2024-05-31